Trial Profile
Phase-II study of AJA777 in patients with functional dyspepsia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs AJA 777 (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Sponsors Ajinomoto Pharma
- 07 Jun 2016 New trial record